Table 1.
Compound | R1 = | R2 =, other | Visual (µM)a |
Neutral red (µM)a |
||||
---|---|---|---|---|---|---|---|---|
EC50 | CC50 | SI50 | EC50 | CC50 | SI50 | |||
8 | [Pirodavir]c | – | 0.86 | >27 | >31 | 0.57 | 17 | 30 |
931 | – | – | >50 | >50 | b | >50 | >50 | b |
formula I | ||||||||
1031 | H | >50 | >50 | b | >50 | >50 | b | |
1131 | H | >100 | >100 | b | >100 | >100 | b | |
1231 | Cl | >32 | 32 | b | >27 | 27 | b | |
formula II (R2 = Cl, unless noted) | ||||||||
1329, 31 | H | Cl | >50 | >50 | b | >36 | 36 | b |
14 | Cl | >100 | >100 | b | >100 | >100 | b | |
15 | Cl | 32 | >100 | >3.1 | 32 | >100 | >3.1 | |
1629, 31 | Cl | 10 | >100 | >10 | 3.2 | 68 | 21 | |
1729 | Cl | 7.7 EC90 | 24 | 3.1SI90 | 9.1 | 24 | 2.6 | |
18 | Cl, X = CH | 32 | >100 | >3.1 | 24 | 86 | 3.6 | |
19 | I | 18 | 100 | 5.6 | 20 | 46 | 2.3 | |
20 | (R) | SCH3 | >100 | >100 | b | 66 | >100 | >1.5 |
2129 | (S) | Cl | 12 | >50 | >4.2 | 2.3 | >50 | >22 |
22 | (S) | Cl | >100 | >100 | b | >100 | >100 | b |
23 | (S) | Cl, X = CH | >100 | >100 | b | >63 | 63 | b |
24 | (S) | SCH3, X = CH | >100 | >100 | b | >100 | >100 | b |
25 | (R) | Cl | 32 | >100 | >3.1 | 31 | >100 | >3.2 |
2629 | (R) | Cl | 16 | >50 | >3.1 | 2.3 | >50 | >22 |
2729 | (S) | Cl | 16 | >50 | >3.1 | 5.3 | >50 | >9.4 |
2829 | (R) | Cl | 16 | >50 | >3.1 | 8 | 13 | 1.6 |
2929 | (S) | Cl | 16 | >50 | >3.1 | 9.3 | 14 | 1.5 |
3031 | Cl | 16 | 50 | 3.1 | >28 | 28 | b | |
formula III, R3 = H | ||||||||
3127, 28, 31 | Cl | 3.6 | >100 | >28 | 3.4 | 34 | 10 | |
3228 | H | >50 | >50 | b | >50 | >50 | b | |
3328 | I | >50 | >50 | b | >50 | 50 | b | |
3430 | I,X = CH | >100 | 100 | b | 32 | 44 | 1.4 | |
3528 | NHNH2 | >50 | >50 | b | >50 | 50 | b | |
3628 | >50 | >50 | b | >50 | 50 | b | ||
3728 | >50 | >50 | b | >50 | 50 | b | ||
3828 | (R) | Cl | 16 | >50 | >3.1 | 12 | >50 | >4.2 |
3928 | (R) | Cl | 21 | >50 | >2.4 | 8.1 | 9.9 | 1.2 |
4028 | (S) | Cl | 18 | >50 | >2.8 | >7.6 | 7.6 | b |
4128 | Cl | >50 | >50 | b | >10 | 10 | b | |
4231 | Cl | >16 | 16 | b | >17 | 17 | b | |
4327 | Cl | >50 | >50 | b | >23 | 23 | b | |
formula III, R3 = H | ||||||||
4429 | Cl, R3 = CO2CH2CH3 | >50 | >50 | b | >1.5 | 1.5 | b | |
4529 | Cl, R3 = CO2H | >50 | >50 | b | >50 | 50 | b | |
4629 | Cl, R3 = CONH(CH2)2NH2 | >50 | >50 | b | >50 | 50 | b | |
4729 | Cl, R3 = CONH(CH2)3NH2 | >50 | >50 | b | >50 | 50 | b | |
48 | (R) | Cl, R3 = CH2F | 3.6 | 36 | 10 | 3.0 | 33 | 11 |
49 | (R) | Cl, R3 = CH2Cl | 4.3 | 32 | 7.4 | 3.9 | 27 | 6.9 |
50 | (R) | Cl, R3 = CH2SCH3 | >32 | 32 | b | 8.4 | 32 | 3.8 |
51 | (R) | Cl, R3 = CH2N3 | 5.3 | 32 | 6.0 | 4.8 | 32 | 6.7 |
52 | (R) | Cl, R3 = CH2NH2 | >32 | 32 | b | >32 | 32 | b |
Footnotes:
a - EC50 (or EC90 when indicated) - compound concentration that reduces viral replication by 50% (or 90%). CC50 ‐ compound concentration that reduces cell viability by 50%. SI50 (selectivity index) = CC50/EC50.
b - undetermined low value.
c - EC50 values of pirodavir were in the range of 0.036–0.32 (visual) and 0.056–0.22 (neutral red) µg/mL.